Carbamic Acid

Carbamic Acid

SCHEMBL21986555

CCSSCC.NC(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.47
FFAR3 O14843 2/20 0.39
NOS1 P29475 4/20 0.36
TSHR P16473 3/20 0.36
CYP2C19 P33261 3/20 0.36
ALDH1A1 P00352 3/20 0.36
ALOX15 P16050 2/20 0.36
CYP2D6 P10635 2/20 0.36
NOS3 P29474 2/20 0.36
NOS2 P35228 2/20 0.36
CYP1A2 P05177 1/20 0.36
BLM P54132 2/20 0.35
LMNA P02545 2/20 0.35
PMP22 Q01453 1/20 0.35
TDP1 Q9NUW8 4/20 0.35
LDHA P00338 1/20 0.33
LDHB P07195 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL29007335 0.97 ACHE (0.44) ACHEFFAR3NOS1TSHRCYP2C19
Carbamic Acid SCHEMBL28546467 0.97 ACHE (0.44) ACHEFFAR3NOS1TSHRCYP2C19
Acetic Acid SCHEMBL3228026 0.83 FFAR3 (0.50) FFAR3TSHRCYP2C19ALDH1A1CYP2D6
Carbamic Acid SCHEMBL29007334 0.81 FFAR3 (0.35) FFAR3NOS1TSHRCYP2C19ALDH1A1
Diethyl Sulfide SCHEMBL11503638 0.80
SCHEMBL17340316 0.79
Carbamic Acid SCHEMBL27929645 0.78
Carbamic Acid SCHEMBL21986556 0.78
Diethyl Sulfide SCHEMBL10511075 0.78 TSHR (0.44) ACHEFFAR3NOS1TSHRCYP2C19
SCHEMBL14157228 0.77 TDP1 (0.63) NOS1TSHRCYP2C19ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3914241-A1 ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME Yale University (US) 2021-12-01 EP disclosed
US-20210085796-A1 ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME YALE UNIVERSITY 2021-03-25 US disclosed
WO-2020154672-A1 ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME YALE UNIVERSITY (US) 2020-07-30 WO disclosed
CN-108484807-B Preparation method of rigid chain liquid crystal polymer with perylene bisimide (PDI) as side group and photoelectric property 湘潭大学 2020-06-19 CN disclosed
EP-3659307-A1 Anticancer Drugs and Methods of Making and Using Same Yale University (US) 2020-06-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210085796-A1 ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME MTHFD1, DHFR, ABCG2 ACHE 1977/4885FFAR3 3000/4885NOS1 3718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.